We are live on ! Find out more
BWP

Baldwin Wealth Partners Portfolio holdings

AUM $1.53B
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+85.86%
5 Year Est. Return
+102.78%
10 Year Est. Return
+445.81%
AUM
$901M
AUM Growth
-$14M
Cap. Flow
-$24.1M
Cap. Flow %
-2.68%
Top 10 Hldgs %
40.41%
Holding
685
New
23
Increased
77
Reduced
128
Closed
36

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$5.27M
2
PLD icon
Prologis
PLD
+$2.64M
3
JPM icon
JPMorgan Chase
JPM
+$1.45M
4
AXSM icon
Axsome Therapeutics
AXSM
+$663K
5
MSI icon
Motorola Solutions
MSI
+$580K

Top Sells

Rank Stock Value
1
MXIM
Maxim Integrated Products
MXIM
+$5.29M
2
BND icon
Vanguard Total Bond Market
BND
+$3.42M
3
AMGN icon
Amgen
AMGN
+$3.04M
4
BX icon
Blackstone
BX
+$2.02M
5
PYPL icon
PayPal
PYPL
+$1.73M

Sector Composition

Rank Sector Weight
1 Technology 19.69%
2 Financials 16.3%
3 Healthcare 11.85%
4 Communication Services 9.91%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
226
CME Group
CME
$94.4B
$152K 0.02%
788
CP icon
227
Canadian Pacific Kansas City
CP
$79.7B
$152K 0.02%
2,333
+257
+12% +$18.3K
BAB icon
228
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$149K 0.02%
4,520
VEEV icon
229
Veeva Systems
VEEV
$34.4B
$144K 0.02%
500
-300
-38% -$95.2K
TEVA icon
230
Teva Pharmaceuticals
TEVA
$40.1B
$141K 0.02%
14,500
MGM icon
231
MGM Resorts International
MGM
$11.7B
$140K 0.02%
3,250
NOMD icon
232
Nomad Foods
NOMD
$1.66B
$138K 0.02%
5,000
BIIB icon
233
Biogen
BIIB
$30.8B
$136K 0.02%
480
+80
+20% +$26.2K
GSK icon
234
GSK
GSK
$103B
$134K 0.01%
2,807
+119
+4% +$5.98K
CIM
235
Chimera Investment
CIM
$1.06B
$129K 0.01%
2,900
MRNA icon
236
Moderna
MRNA
$22.8B
$129K 0.01%
334
-176
-35% -$64.9K
HTD
237
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$910M
$128K 0.01%
5,592
XYZ
238
Block Inc
XYZ
$50.4B
$125K 0.01%
523
TOTL icon
239
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.03B
$123K 0.01%
2,538
-15
-0.6% -$727
ARCC icon
240
Ares Capital
ARCC
$14.1B
$122K 0.01%
6,000
KO icon
241
Coca-Cola
KO
$372B
$122K 0.01%
2,320
IPGP icon
242
IPG Photonics
IPGP
$3.99B
$121K 0.01%
761
PLTR icon
243
Palantir
PLTR
$390B
$120K 0.01%
5,000
ZEN
244
DELISTED
ZENDESK INC
ZEN
$120K 0.01%
1,034
+200
+24% +$25.8K
EWJ icon
245
iShares MSCI Japan ETF
EWJ
$22.4B
$117K 0.01%
1,659
BGFV
246
DELISTED
Big 5 Sporting Goods
BGFV
$115K 0.01%
5,000
FND icon
247
Floor & Decor
FND
$6.46B
$115K 0.01%
956
VSS icon
248
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.6B
$110K 0.01%
820
DXJ icon
249
WisdomTree Japan Hedged Equity Fund
DXJ
$7.2B
$108K 0.01%
1,703
MFIC icon
250
MidCap Financial Investment
MFIC
$799M
$108K 0.01%
8,333

Similar funds

Baldwin Wealth Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Baldwin Wealth Partners held 685 positions worth $901M, down 1.5% from $915M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baldwin Wealth Partners's Q3 2021 filing shows 23 new, 77 increased, 128 reduced and 36 closed positions. Its largest new stake was HCA Healthcare: 2,200 shares worth $534K. The largest sale was Maxim Integrated Products, an estimated $5.29M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Baldwin Wealth Partners's largest Q3 2021 buy was HCA Healthcare: 2,200 shares worth $534K.
  • Baldwin Wealth Partners added most to Analog Devices in Q3 2021, an estimated $5.27M increase.
  • Baldwin Wealth Partners's biggest Q3 2021 reduction was Vanguard Total Bond Market, cutting an estimated $3.42M.
  • Baldwin Wealth Partners fully exited Maxim Integrated Products in Q3 2021, selling an estimated $5.29M.
  • Baldwin Wealth Partners's ten largest holdings make up 40% of its $901M portfolio in Q3 2021.
  • Baldwin Wealth Partners opened 23 new positions and closed 36 in Q3 2021.
  • Baldwin Wealth Partners's portfolio value fell 1.5% quarter-over-quarter to $901M.

Based on Baldwin Wealth Partners's 13F filing for Q3 2021, filed 27 Oct 2021.